×
  • Category
  • Type
  • Advanced

The switch from ROTARIX to ROTAVAC in Ghana: Answers to four key questions

Calculateur du coût des vaccins antirotavirus

Calculateur du coût des vaccins pneumococcique conjugués

Implications Économiques du Changement de Vaccin Antirotavirus dans le Programme de Vaccination de la Palestine

Impact and cost-effectiveness of an injectable rotavirus vaccine candidate compared to oral rotavirus vaccines

Estimating total spending by source of funding on routine and supplementary immunisation activities in low-income and middle-income countries, 2000–17: a financial modelling study

Group B Streptococcus vaccine: full value of vaccine assessment. Financial analysis

Cost of vaccine delivery strategies in low- and middle-income countries during the COVID-19 pandemic

Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines - Q&A for Sessions #02 and #03: COVID-19 Vaccination: Costing for Scale-up

PAHO Revolving Fund

Contingent Valuation: A Pilot Study for Eliciting Willingness to Pay for a Reduction in Mortality From Vaccine-Preventable Illnesses for Children and Adults in Bangladesh

Return On Investment From Immunization Against 10 Pathogens In 94 Low- And Middle-Income Countries, 2011–30

Costs of Immunization Programs for 10 Vaccines in 94 Low- and Middle-Income Countries From 2011 to 2030

Economic Benefits of Immunization for 10 Pathogens in 94 Low- and Middle-Income Countries From 2011 to 2030 Using Cost-of-Illness and Value-of-Statistical-Life Approaches

The economic burden of measles in children under five in Bangladesh

The Economic Case for Global Vaccinations: An Epidemiological Model with International Production Networks

MI4A Vaccine Purchase Data for Countries - 2020

Using PATH’s Vaccine Cost Calculators to inform immunization decision-making

Economic Implications of Switching Rotavirus Vaccine Products in Palestine's Immunization Program

The cost of routine immunization outreach in the context of COVID-19: estimates from Tanzania and Indonesia